Search company, investor...

Predict your next investment

Boulder Ventures company logo
Venture Capital
boulderventures.com

Investments

169

Portfolio Exits

46

Funds

8

Service Providers

3

About Boulder Ventures

Boulder Ventures provides funding for entrepreneurs building technology companies. It helps start-up, early-stage, and emerging-growth companies, and invests primarily in the information technology and life sciences sectors. The company was founded in 1995 and is based in Boulder, Colorado.

Headquarters Location

1941 Pearl Street Suite 300

Boulder, Colorado, 80302,

United States

303-444-6950

Want to inform investors similar to Boulder Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Boulder Ventures News

CU’s Marvin Caruthers awarded inaugural prize, $400,000 for biotech work

Jun 30, 2023

| UPDATED: June 29, 2023 at 6:11 p.m. Marvin Caruthers, a prestigious University of Colorado Boulder biotechnology professor and researcher, has been named the first winner of the Richard N. Merkin Prize in Biomedical Technology for his work in DNA synthesis. “The chemical reactions that he discovered in the early 1980s to accurately and quickly assemble nucleotides into strands of DNA provided an essential element in the development of modern molecular medicine,” Merkin Prize organizers said in a news release. “Today, scientists use these reactions to produce customizable DNA and RNA molecules that enable genetic sequencing, drug and vaccine development, pathogen tests, cancer diagnostics, and many aspects of basic biomedical research.” The prize, which comes with a $400,000 prize, was created by the Merkin Family Foundation and is administered by the Broad Institute of the Massachusetts Institute of Technology and Harvard University. “I am honored to acknowledge the incredible and transformative impact of Dr. Caruthers’ technology on human health over the past four decades,” Merkin, founder and CEO of the health care system Heritage Provider Network, said in the release. “He deserves our support and recognition. I hope this prize not only raises awareness of this work but underscores and encourages others to realize the broader importance of developing new scientific technologies to transform health care.” Caruthers, named in 2022 as one of the Boulder Valley’s most iconic business figures of the last 40 years by BizWest, is CU’s distinguished professor of biochemistry, and has formed numerous biotechnology companies, including Genomica Corp., which was bought in 2001 by San Francisco-based Exelixis Inc.; Thousand Oaks, California-based Amgen Inc.; and Foster City, California-based Applied Biosystems Inc. He’s also known for helping form NeXstar Pharmaceuticals Inc., which was acquired by Foster City, California-based Gilead Sciences Inc.; Ribozyme Pharmaceuticals Inc.; as well as Boulder-based Array Biopharma Inc., among others. Caruthers was awarded a 2003 Esprit Entrepreneur Lifetime Achievement award and was inducted into the National Inventors Hall of Fame in 2018. He also keeps his hand in many of the other companies he helped start. Many of those companies were in collaboration with Kyle Lefkoff. When Lefkoff started Boulder Ventures Ltd. in 1995, Caruthers became a founding investor and a founding member of the company’s investment committee. Besides all his biotech endeavors, he and his late wife, Jennie, created the Caruthers Family Foundation, which focuses on helping impoverished children get medical and dental care. He also donated $20 million to the University of Colorado to help construct the Jennie Smoly Caruthers Biotechnology Building, an interdisciplinary biotechnology building that houses the BioFrontiers Institute. The donation was the largest by a faculty member and one of the largest in the school’s history. This article was first published by BizWest, an independent news organization, and is published under a license agreement. © 2023 BizWest Media LLC. You can view the original here: CU’s Marvin Caruthers awarded inaugural prize, $400K, for biotech work Tags:

Boulder Ventures Investments

169 Investments

Boulder Ventures has made 169 investments. Their latest investment was in ClinOne as part of their Series A - II on April 4, 2023.

CBI Logo

Boulder Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

4/14/2023

Series A - II

ClinOne

$10.51M

Yes

6

2/13/2023

Series C - III

Zenoss

No

1

1/23/2023

Series F

AdWerx

$1.28M

No

3

6/8/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

4/15/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/14/2023

2/13/2023

1/23/2023

6/8/2022

4/15/2022

Round

Series A - II

Series C - III

Series F

Series B

Seed VC

Company

ClinOne

Zenoss

AdWerx

Subscribe to see more

Subscribe to see more

Amount

$10.51M

$1.28M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

6

1

3

10

10

Boulder Ventures Portfolio Exits

46 Portfolio Exits

Boulder Ventures has 46 portfolio exits. Their latest portfolio exit was Mineralys Therapeutics on February 10, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/10/2023

IPO

$99M

Public

5

9/12/2022

Acquired

$99M

7

7/19/2022

Acquired

$99M

1

4/26/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/30/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/10/2023

9/12/2022

7/19/2022

4/26/2022

7/30/2021

Exit

IPO

Acquired

Acquired

Acquired

Acquired

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Public

Subscribe to see more

Subscribe to see more

Sources

5

7

1

10

10

Boulder Ventures Fund History

8 Fund Histories

Boulder Ventures has 8 funds, including Boulder Ventures VIII.

Closing Date

Fund

Fund Type

Status

Amount

Sources

7/12/2022

Boulder Ventures VIII

$58M

1

12/31/2018

Boulder Ventures VII

Subscribe to see more

Subscribe to see more

10

6/30/2014

Boulder Ventures VI

Subscribe to see more

Subscribe to see more

10

12/31/2007

Boulder Ventures V LP

Subscribe to see more

Subscribe to see more

$99M

10

2/1/2001

Boulder Ventures IV LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

7/12/2022

12/31/2018

6/30/2014

12/31/2007

2/1/2001

Fund

Boulder Ventures VIII

Boulder Ventures VII

Boulder Ventures VI

Boulder Ventures V LP

Boulder Ventures IV LP

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$58M

$99M

$99M

Sources

1

10

10

10

10

Boulder Ventures Service Providers

3 Service Providers

Boulder Ventures has 3 service provider relationships

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Service Provider

Subscribe to see more

Subscribe to see more

Associated Rounds

Provider Type

Counsel

Subscribe to see more

Subscribe to see more

Service Type

General Counsel

Subscribe to see more

Partnership data by VentureSource

Boulder Ventures Team

9 Team Members

Boulder Ventures has 9 team members, including current Founder, General Partner, Kyle Lefkoff.

Name

Work History

Title

Status

Kyle Lefkoff

Founder, General Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Kyle Lefkoff

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder, General Partner

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.